Clovis Oncology is a renowned brand specializing in oncology research and development. As a leading player in the field, they are committed to advancing cancer treatments and improving patient outcomes. Clovis Oncology offers a range of innovative products and services designed to address the complex challenges of cancer.

With a strong focus on precision medicine, they develop targeted therapies that aim to treat specific types of cancer more effectively and with fewer side effects. Their flagship product, Rubraca® (rucaparib) tablets, is owned by pharma& Schweiz GmbH and continues to make significant strides in the treatment of malignancies. In addition to their cutting-edge pharmaceuticals, Clovis Oncology also provides comprehensive support and information to healthcare professionals, patients, and caregivers.

Through their dedication to research, development, and patient advocacy, Clovis Oncology is at the forefront of the fight against cancer